Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR419 in Peripheral Neuropathic Pain
NCT04494815Phase 2Completed
- Sponsor
- Shanghai SIMRD Biotechnology Co., Ltd.
- Start
- Sep 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sr419 in Peripheral neuropathic pain, postherpetic neuralgia (PHN), diabetic peripheral neuropathy (DPN), sponsored by Shanghai SIMRD Biotechnology Co., Ltd.. Started Sep 2020; status: completed.
02
Drugs
sr419
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04494815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494815.